companies
3 Point Analysis | Will AstraZeneca’s paused COVID-19 vaccine trial impact the ongoing trials in India?
Moneycontrol's Sakshi Batra does a 3 Point Analysis to find out the reasons behind the pause of the trial and how will this impact India
first published: Sep 9, 2020 09:05 pm
